secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001384101-26-000029
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte Q1 2026 revenue $139.1M (+21% YoY); GAAP net income $28.7M, adj. EBITDA $42.8M
--------------------------------------------------------------------------------

- Total revenue $139.1M (+21% YoY); testing revenue $135.1M (+26% YoY).
- GAAP net income $28.7M (20.6% of revenue); adjusted EBITDA $42.8M (30.8% of revenue).
- Decipher revenue $86.5M (+30%); Afirma revenue $46.4M (+21%).
- Testing volume 45,248 (+19%); Decipher tests ~28,000 (+24%), Afirma ~17,200 (+12%).
- Cash from operations $35.2M; cash & investments $439.1M; added Haas as CDTO and Ward as CHRO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410126000029/0001384101-26-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410126000029/vcyt-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001384101-26-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer